Correction
Published on 07 Feb 2023
Corrigendum: Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1149399
- 1,276 views
- Frontiers in Oncology
- Breast Cancer
- Articles
Type at least 3 characters
665 articles
Original Research
Published on 06 Feb 2023
Transcription factor E2F8 is a therapeutic target in the basal-like subtype of breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1038787
- 15,797 views
- 8 citations
Original Research
Published on 06 Feb 2023
Volume change rate before and after neoadjuvant systemic therapy of breast cancer is an efficacious evaluation index to predict pathological complete response
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.910869
- 2,030 views
- 2 citations
Original Research
Published on 02 Feb 2023
Highly expressed CENPL is correlated with breast cancer cell proliferation and immune infiltration
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1046774
- 2,457 views
- 4 citations
Original Research
Published on 02 Feb 2023
The level of kinesiophobia in breast cancer women undergoing surgical treatment
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1010315
- 6,380 views
- 13 citations
Systematic Review
Published on 02 Feb 2023
Clinicopathologic characteristics and prognostic significance of HER2-low expression in patients with early breast cancer: A systematic review and meta-analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1100332
- 3,807 views
- 13 citations
Original Research
Published on 01 Feb 2023
Analysis of prognostic factors and construction of prognostic models for triple-positive breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1071076
- 2,912 views
- 4 citations
Original Research
Published on 31 Jan 2023
End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1028825
- 2,627 views
- 5 citations
Original Research
Published on 31 Jan 2023
The optimal regional irradiation volume for breast cancer patients: A comprehensive systematic review and network meta-analysis of published studies
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1081201
- 2,855 views
- 1 citation
Review
Published on 30 Jan 2023
Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1083297
- 5,145 views
- 7 citations
Original Research
Published on 30 Jan 2023
Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1002186
- 5,263 views
- 12 citations
Original Research
Published on 30 Jan 2023
The efficacy and safety of epirubicin and cyclophosphamide combined with pyrotinib in neoadjuvant treatment for HER2-positive breast cancer: A real-world study
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1041111
- 3,080 views
Review
Published on 27 Jan 2023
Correlation between the Warburg effect and progression of triple-negative breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1060495
- 11,375 views
- 36 citations
Original Research
Published on 26 Jan 2023
A nomogram based on combining clinical features and contrast enhanced ultrasound is not able to identify Her-2 over-expressing cancer from other breast cancers
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1035645
- 1,928 views
- 1 citation
Original Research
Published on 25 Jan 2023
Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective study
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.978985
- 6,703 views
- 21 citations
Review
Published on 25 Jan 2023
Emerging functions of C/EBPβ in breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1111522
- 6,980 views
- 26 citations